Table 1 Patients’ demographic and clinical characteristics
Females (n, %) | 143 | 47,7 |
Age (median, range) | 3 | 0.2 - 17 |
Comorbidity (n, %) | 83 | 27,7 |
celiac disease | 4 | 1,3 |
diabetes | 0 | 0,0 |
thyreopathy | 2 | 0,7 |
asthma | 32 | 10,7 |
rhynitis | 30 | 10,0 |
food allergy | 10 | 3,3 |
other | 16 | 5,3 |
Years of age at AD diagnosis (median, range) | 0,4 | 0-13 |
AD duration in years (median, range) | 1,8 | 0-15 |
Disease evolution (n, %) | ||
stable | 43 | 14,3 |
periodic relapses | 164 | 54,7 |
worsening | 68 | 22,7 |
improving | 29 | 9,7 |
irregular | 21 | 7,0 |
Treatment (n, %) | ||
moisturizers | 241 | 84,0 |
topical steroids | 236 | 82,2 |
systemic steroids | 56 | 19,5 |
topical immunosuppressants | 31 | 10,8 |
systemic immunosuppressants | 10 | 3,5 |
diet | 81 | 28,2 |
other | 31 | 10,8 |
SCORAD (n, %) | ||
mild | 114 | 39,7 |
moderate | 125 | 43,6 |
severe | 52 | 18,1 |
Therapeutic education (n, %) | 201 | 67 |